Results 21 to 30 of about 361,585 (263)
Pharmacogenetics and personalized medicine
Pharmacogenetics aims to identify genetic differences between individuals that may influence the response to drug therapy, improving their effectiveness and safety. Associated with the pharmacogenetics emerges ‘personalized medicine’.
Miguel Brito
doaj +1 more source
Background Identifying biomarkers related to the diagnosis and treatment of gastric cancer (GC) has not made significant progress due to the heterogeneity of tumors.
Bo-Kyung Kim +16 more
doaj +1 more source
Personalized medicine in dentistry
Personalized medicine is a branch of medicine that proposes customization of healthcare in which decisions and treatment are tailored according to individual patient needs.
Pushpa S Pudakalkatti +3 more
doaj +1 more source
Background Myeloid sarcoma (MS) is a very rare condition, develops both in patients with other hematological neoplasms, and as isolated tumor. MS of the gynecologic tract is extremely rare.
Aleksina Shatilova +15 more
doaj +1 more source
Personalized Education: Analog of Personalized Medicine? [PDF]
This chapter discusses the role of genetically influenced normal-range intelligence in educational achievement and attainment. I suggest that there is evidence that we have developed an educational system that reinforces genetic disadvantage contributing to low educational achievement and genetic advantage contributing to high educational achievement ...
openaire +1 more source
Empowering personalized medicine
In recent decades, significant progress has been made in understanding the molecular characteristics of cancer and its microenvironment, leading to the development of life-saving treatments.
Oliwia Piwocka +2 more
doaj +1 more source
Personalized Zebrafish Models for Fusion‐Positive Pediatric Sarcomas
ABSTRACT Clinical sequencing efforts have revolutionized our approaches to categorizing pediatric cancers in real time. This has dramatically improved our ability to profile pediatric tumors, identify actionable vulnerabilities, and influence clinical care.
Lisa H. Hall +2 more
wiley +1 more source
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens +4 more
wiley +1 more source
Background. Unbiased studies using different genome-wide methods have identified a great number of candidate biomarkers for diagnosis and treatment response in pediatric ulcerative colitis (UC).
Xinxiu Li +6 more
doaj +1 more source

